Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 92   

Articles published

GALE 1.90 +0.01 (0.53%)
price chart
Could Galena Biopharma, Inc. Be Running Out of Money?
Today, we're going to take a closer look at small-cap biopharmaceutical company Galena Biopharma (NASDAQ: GALE ) to get a better bead on what its current cash situation looks like, to determine whether or not it could be running out of money, and to ...
Galena Biopharma Inc (NASDAQ:GALE) is losing money
Let's look at a small end biopharmaceutical company, Galena Biopharma Inc (NASDAQ:GALE), so we can get a vivid perspective regarding what the situation looks like.
Galena Biopharma Announces Release of Special Committee Report and ...
Galena Biopharma, Inc. GALE, -0.27% today announced the release of a report prepared by the former Special Committee of Galena's Board of Directors regarding the Company's 2012-2014 market visibility campaigns and the sale of shares by insiders in the ...
Related articles »  
Stocks to Watch: Galena Biopharma, Fiserv , Harmonic Inc. , FLIR Systems
Galena Biopharma, Inc. (NASDAQ:GALE) : Announced the first patient has been dosed in the GALE-401, or Anagrelide Controlled Release, Phase 2 Clinical Trial.
Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for ...
PORTLAND, Ore., Oct. 8, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full ...
Related articles »  
Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away ...
One such stock that you may want to consider dropping is Galena Biopharma, Inc. ( GALE ) which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the ...
Related articles »  
Galena Biopharma Inc. (GALE) Hits New 52-week Low During October 13 Session
Galena Biopharma Inc. (GALE) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $1.72, Galena Biopharma Inc. dropped to $1.56 for a new 52-week low. By the closing bell, the company's stock was at ...
Related articles »  
2 Factors Affecting Biotechs: Novavax, Inc. (NVAX), Galena Biopharma (GALE ...
Novavax, Inc. (NASDAQ:NVAX), Galena Biopharma Inc (NASDAQ:GALE), Northwest Biotherapeutics, Inc (NASDAQ:NWBO), StemCells Inc (NASDAQ:STEM), Chimerix Inc (NASDAQ:CMRX) and Novavax, Inc. (NASDAQ:NVAX) each saw big rally on Thursday.
Related articles »  
Galena Biopharma Receives Notice of Allowance of Improvement Patent for ...
PORTLAND, Ore., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. GALE, +4.92% a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that that address major medical needs across the full ...
Galena gets NOA for NeuVax patent app in Japan (GALE)  Seeking Alpha (registration)
Latest On Galena Biopharma (GALE), Skyworks Solutions (SWKS), Goodrich ...  USMarketsDaily (blog)
Related articles »  
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena ...
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Novavax Inc. (NASDAQ: NVAX), Galena Biopharma Inc. (NASDAQ: GALE), Geron Corporation (NASDAQ: GERN), and Celldex Therapeutics Inc.
Related articles »